NDC 59762-0122

Trandolapril and Verapamil Hydrochloride ER

Trandolapril And Verapamil Hydrochloride

Trandolapril and Verapamil Hydrochloride ER is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Greenstone Llc. The primary component is Trandolapril; Verapamil Hydrochloride.

Product ID59762-0122_1cbedd36-6af5-df5e-5b56-1548603c0d95
NDC59762-0122
Product TypeHuman Prescription Drug
Proprietary NameTrandolapril and Verapamil Hydrochloride ER
Generic NameTrandolapril And Verapamil Hydrochloride
Dosage FormTablet, Film Coated, Extended Release
Route of AdministrationORAL
Marketing Start Date2015-02-25
Marketing CategoryNDA / NDA
Application NumberNDA020591
Labeler NameGreenstone LLC
Substance NameTRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE
Active Ingredient Strength4 mg/1; mg/1
Pharm ClassesAngiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 59762-0122-1

100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59762-0122-1)
Marketing Start Date2015-02-25
Marketing End Date2021-08-18
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 59762-0122-1 [59762012201]

Trandolapril and Verapamil Hydrochloride ER TABLET, FILM COATED, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA020591
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-02-25
Marketing End Date2021-08-18

Drug Details

Active Ingredients

IngredientStrength
TRANDOLAPRIL4 mg/1

OpenFDA Data

SPL SET ID:d776d5d1-cb5b-80f9-e00c-75d4c3ae4d20
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 897844
  • 897781
  • 897853
  • 897783
    • UPC Code
  • 0359762012210
  • 0359762014214
  • 0359762013217

    • Pharmacological Class

    • Angiotensin Converting Enzyme Inhibitor [EPC]
    • Angiotensin-converting Enzyme Inhibitors [MoA]
    • P-Glycoprotein Inhibitors [MoA]
    • Calcium Channel Antagonists [MoA]
    • Calcium Channel Blocker [EPC]
    • Cytochrome P450 3A4 Inhibitors [MoA]
    • Cytochrome P450 3A Inhibitors [MoA]

    Medicade Reported Pricing

    59762012201 TRANDOLAPRIL-VERAPAMIL ER 4-240 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Trandolapril and Verapamil Hydrochloride ER" or generic name "Trandolapril And Verapamil Hydrochloride"

    NDCBrand NameGeneric Name
    0074-3287TarkaTrandolapril and Verapamil Hydrochloride
    0074-3289TarkaTrandolapril and Verapamil Hydrochloride
    0074-3290TarkaTrandolapril and Verapamil Hydrochloride
    59762-0122Trandolapril and Verapamil HydrochlorideTrandolapril and Verapamil Hydrochloride
    59762-0132Trandolapril and Verapamil HydrochlorideTrandolapril and Verapamil Hydrochloride
    59762-0142Trandolapril and Verapamil HydrochlorideTrandolapril and Verapamil Hydrochloride
    68462-294Trandolapril and Verapamil HydrochlorideTrandolapril and Verapamil Hydrochloride
    68462-295Trandolapril and Verapamil HydrochlorideTrandolapril and Verapamil Hydrochloride
    68462-296Trandolapril and Verapamil HydrochlorideTrandolapril and Verapamil Hydrochloride
    68462-329Trandolapril and Verapamil HydrochlorideTrandolapril and Verapamil Hydrochloride
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.